
Analysts have recently updated ratings on three high-yielding materials stocks: Huntsman (HUN), FMC Corporation (FMC), and The Chemours Company (CC). Huntsman saw mixed analyst actions with JP Morgan maintaining an Overweight rating but lowering the price target to $20, while Wells Fargo downgraded the stock to Equal-Weight with a reduced price target of $13; Huntsman also completed a strategic review of its European Maleic Anhydride business. FMC received a maintained Overweight rating from Keybanc with an increased price target of $53, contrasting with Seaport Global's maintained Buy rating but lowered price target of $55, following the company's issued lower-than-expected Q2 adjusted EPS guidance. Chemours had Morgan Stanley maintain an Equal-Weight rating but cut the price target to $15, offset by Mizuho upgrading the stock to Outperform with a $19 price target, after the company reported worse-than-expected Q1 adjusted EPS results.
The materials sector features several companies with high dividend yields, attracting investor attention during market turbulence; however, recent analyst activity and company-specific developments paint a mixed and cautious picture. Huntsman Corporation (HUN), with an 8.55% dividend yield, saw JP Morgan maintain an Overweight rating but slash its price target from $22 to $20 on May 5, 2025, while Wells Fargo downgraded HUN to Equal-Weight, lowering its target from $17 to $13 on the same date; this followed Huntsman's announcement on May 28 of completing the strategic review of its European Maleic Anhydride business. FMC Corporation (FMC), yielding 5.95%, received a maintained Overweight rating from Keybanc with a price target increase from $49 to $53 on May 2, 2025, yet Seaport Global, while maintaining a Buy, cut its target from $72 to $55 on March 5, 2025, after FMC issued below-estimate Q2 adjusted EPS guidance on April 30. The Chemours Company (CC), offering a 3.30% yield, was upgraded to Outperform by Mizuho with a $19 price target on March 27, 2025, but Morgan Stanley maintained an Equal-Weight rating while cutting its price target from $22 to $15 on May 12, 2025, subsequent to Chemours reporting worse-than-expected Q1 adjusted EPS results on May 6. These updates, largely from analysts with accuracy rates between 61% and 78%, highlight underlying performance concerns, such as earnings misses and disappointing guidance, which temper the attractiveness of the current high yields and contribute to an overall cautious sentiment for these specific stocks.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
-0.15
Ticker Sentiment